Category Archives: Regional Comprehensive Economic Partnership

16-nation RCEP talks resume in wake of TPP’s demise

By Eric Johnston, Japan Times KOBE – The 16-nation Regional Comprehensive Economic Partnership, a multilateral agreement that would cover half the world’s population, has reached a major turning point, delegates said Monday at the start of five days of negotiations. … Continue reading

Posted in IPR, Regional Comprehensive Economic Partnership, TPP, Uncategorized | Leave a comment

Civil society, patient groups call on Japan and South Korea to withdraw harmful proposals from RCEP negotiations

By Ramesh Shankar, http://www.pharmabiz.com | February 24, 2017 As 16 countries negotiating the Regional Comprehensive Economic Partnership (RCEP) agreement meet next week in Kobe, Japan, for the seventeenth round of negotiations, civil society and patient groups, including the international medical humanitarian … Continue reading

Posted in Data Exclusivity, IPR, Patent, Patent Term Extension, Regional Comprehensive Economic Partnership, TPP, Uncategorized | Leave a comment

India on stronger footing to resist IPR framework at RCEP

Stiff negotiations on goods, services expected at Kobe meet By Amiti Sen, Hindu BusinessLine | FEBRUARY 23, 2017 India will be on a stronger wicket to oppose the stringent IPR framework being pushed by some members at the next negotiating round … Continue reading

Posted in IPR, Regional Comprehensive Economic Partnership, TPP, Uncategorized | Leave a comment

MSF calls on Japan and South Korea to drop the harmful RCEP measures

Kobe, Japan/New Delhi 22 February 2017 As 16countries negotiating the Regional Comprehensive Economic Partnership (RCEP)agreement meet next week in Kobe, Japan, for the seventeenth round of negotiations, international medical humanitarian organisation Médecins Sans Frontières (MSF) is appealing tothe Japanese and South … Continue reading

Posted in Data Exclusivity, Drug prices, Generics, Patent Term Extension, Regional Comprehensive Economic Partnership, TRIPS, TRIPS plus, Uncategorized | Leave a comment

A ‘New’ Recipe for Trade

By Shalini Bhutani, The Economic & Political Weekly (Vol. 52 Issue No. 7) With other mega regional trade agreements like the Trans–Pacific Partnership in uncertainty, trade treaties like the Regional Comprehensive Economic Partnership will acquire greater significance beyond their original … Continue reading

Posted in IPR policy, Regional Comprehensive Economic Partnership, TPP, Transatlantic Trade and Investment Partnership (TTIP), TRIPS plus, Uncategorized | Leave a comment

TPP is dead, but its legacy lives on

By Arjun Jayadeva, The HinduThe Hindu | February 9, 2017 The Trans-Pacific Partnership was dead long before Donald Trump signed his executive order. But its damaging aspects, like stringent IP provisions, have just migrated to other agreements U.S. President Donald Trump’s … Continue reading

Posted in Data Exclusivity, Evergreening, Patent Term Extension, Regional Comprehensive Economic Partnership, TPP, Uncategorized | Leave a comment

Refuse trade, investment provisions that threaten access to affordable meds

Positive Malaysian Treatment Access & Advocacy Group (MTAAG+) calls on the Malaysian government to reject trade and investment agreement provisions that threaten access to affordable medicines. MTAAG+ asserts the need to make its position and demand known because of the … Continue reading

Posted in Data Exclusivity, Patent Term Extension, Regional Comprehensive Economic Partnership, TPP, TRIPS, TRIPS plus, Uncategorized | Leave a comment